Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
Thijs J. Hagenbeek, Jason R. Zbieg, Marc Hafner, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 812-828
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition
Sayantanee Paul, Thijs J. Hagenbeek, Julien Tremblay, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
MISP Suppresses Ferroptosis via MST1/2 Kinases to Facilitate YAP Activation in Non‐Small Cell Lung Cancer
Fuquan Zhang, Bingtao Huang, Yiming Xu, et al.
Advanced Science (2025)
Open Access
IMPlications of IMP2 in RNA Biology and Disease
J. Das, Ottavia Busia-Bourdain, Khizr M. Khan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2415-2415
Open Access
Activation of YAP/TAZ by gut microbiota via Wnt/β-catenin signaling in cancer development
Shahin Javanmard, Kayhan Ertürk
Academia molecular biology and genomics. (2025) Vol. 2, Iss. 2
Closed Access
The YAP/TEAD4 transcriptional complex in intestinal macrophages promotes M2 polarization and alleviates DSS-induced colitis via the regulation of C/EBPβ
Su Wang, Fei Zou, Mengmeng Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAFV600E Mutated Lung Adenocarcinoma via Survivin Downregulation
Kazutaka Hosoya, Hiroaki Ozasa, Hironori Yoshida, et al.
Cancer Science (2025)
Open Access
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics
Na Li, Yunhe Liu, Ji Yuan Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116694-116694
Closed Access | Times Cited: 4
Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis
Hannah Thrash, Ann Marie Pendergast
Cancers (2023) Vol. 15, Iss. 19, pp. 4701-4701
Open Access | Times Cited: 10
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
Ryan Kanai, Emily Norton, Patrick Stern, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 852-852
Open Access | Times Cited: 3
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer
Motohiro Izumi, Daniel B. Costa, Susumu Kobayashi
Lung Cancer (2024) Vol. 194, pp. 107885-107885
Closed Access | Times Cited: 3
Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP
Swati Singh, Gabriela Bernal Astrain, Ana Maria Hincapie, et al.
EMBO Reports (2024) Vol. 25, Iss. 8, pp. 3574-3600
Closed Access | Times Cited: 3
Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?
Sayantanee Paul, Jessica Sims, Trang Pham, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 3
Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration
Ahmed Fnaiche, Hwai‐Chien Chan, Alexis Paquin, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1746-1753
Closed Access | Times Cited: 7
Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions
Rafael Rosell, Carlos Pedraz‐Valdunciel, Anisha Jain, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 171-182
Closed Access | Times Cited: 2
Trilobatin, a Novel Naturally Occurring Food Additive, Ameliorates Alcoholic Liver Disease in Mice: Involvement of Microbiota–Gut–Liver Axis and Yap/Nrf2 Signaling Pathway
Yang Yi, You Yan, Guiyu Zhan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 43, pp. 23819-23831
Closed Access | Times Cited: 2
In situ enzymatic peptide-based nanomedicine with combined effects for enhanced tumor radio-immunotherapy
Tongxin Gao, Zhilong Wang, Jinhui Zhou, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155437-155437
Closed Access | Times Cited: 2
Pan-Transcriptional Enhanced Associated Domain Palmitoylation Pocket Covalent Inhibitor
J S Kim, Hadong Kim, Jongwan Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18957-18968
Closed Access | Times Cited: 2
The Hippo pathway as an antitumor target: time to focus on
Olga Koroleva, Alexander V. Kurkin, Alexander А. Shtil
Expert Opinion on Investigational Drugs (2024), pp. 1-9
Closed Access | Times Cited: 2
YAP and TAZ orchestrate adaptive resistance to KRAS inhibitors
Alessia Mira, Chiara Ambrogio
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 784-786
Closed Access | Times Cited: 6
Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings
Ahmed Fnaiche, Léa Mélin, Narjara González Suárez, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 95, pp. 129488-129488
Closed Access | Times Cited: 6
YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression
Xuan Li, Hongguang Zhong, Qianqian Shi, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Exploring Protein S-Palmitoylation: Mechanisms, Detection, and Strategies for Inhibitor Discovery
Shaojun Pei, Hai‐long Piao
ACS Chemical Biology (2024) Vol. 19, Iss. 9, pp. 1868-1882
Closed Access | Times Cited: 1
An improved TEAD dominant-negative protein inhibitor to study Hippo YAP1/TAZ-dependent transcription.
Briana Branch, Yao Yuan, Mariastella Cascone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of TP53 and KMT2B Mutations and MYC Amplifications but Similar Survival Compared with Cancers with No CDX2 Induction
Ioannis A. Voutsadakis
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7635-7635
Open Access | Times Cited: 1

Scroll to top